Page results
-
The research aims to improve patient care and safety in acute and critical care, surgical care and perioperative care settings.
-
The psychology team are running this workshop that uses a strengths based narrative approach to enable young people in years 10-13 to discuss the stresses surrounding exams and the additional challenges that having health problems add.
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
The trial results are good news for non-small cell lung cancer patients who are not eligible for standard of care platinum-based chemotherapy.
-
A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.
-
UCLH has formed a partnership with the Business Design Centre in Islington to deliver a second COVID-19 large scale vaccination centre.
-
Jean Degala tells us how the right support, teamwork, effective communication, determination and dedication have helped her grow into the role.
-
Prescilia from Hackney was one of the first patients to be treated at the UCLH proton beam therapy centre which opened in December 2021.
-
'Bolus: education delivered stat' is a podcast exploring the haematology speciality, created for nurses, junior doctors and allied healthcare professionals.
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
File results
-
FOI/2023/0591 - Healthcare Assistants agency rates 2023
-
FOI/2023/0592 - Procurement staff organisation chart
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0532 - Patient treatment/ care/ consent